Liraglutide improves cognitive function by reducing amyloid-beta peptide accumulation and inhibiting inflammation in 5 × FAD mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Liraglutide improves cognitive function by reducing amyloid-beta peptide accumulation and inhibiting inflammation in 5 × FAD mice.
- Published In:
- The journals of gerontology. Series A, Biological sciences and medical sciences, 81(2) (2026)
- Authors:
- Qi, Liqin, Lin, Lijing, Zheng, Jiaping, Liu, Xiaoying, Liu, Xiaohong, Chen, Zhou, Liu, Libin
- Database ID:
- RPEP-15937
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15937APA
Qi, Liqin; Lin, Lijing; Zheng, Jiaping; Liu, Xiaoying; Liu, Xiaohong; Chen, Zhou; Liu, Libin. (2026). Liraglutide improves cognitive function by reducing amyloid-beta peptide accumulation and inhibiting inflammation in 5 × FAD mice.. The journals of gerontology. Series A, Biological sciences and medical sciences, 81(2). https://doi.org/10.1093/gerona/glaf265
MLA
Qi, Liqin, et al. "Liraglutide improves cognitive function by reducing amyloid-beta peptide accumulation and inhibiting inflammation in 5 × FAD mice.." The journals of gerontology. Series A, 2026. https://doi.org/10.1093/gerona/glaf265
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide improves cognitive function by reducing amyloid-..." RPEP-15937. Retrieved from https://rethinkpeptides.com/research/qi-2026-liraglutide-improves-cognitive-function
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.